文献速递妇科生殖医学

白细胞介素-10在子宫内膜异位症中并非抗纤维化而是促纤维化:体外处理子宫内膜异位症间质细胞可促进肌成纤维细胞增殖及I型胶原蛋白表达

IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression.
PubMed 文献 · Hum Reprod · 2023-01-01

本研究通过体外实验分析54例深部子宫内膜异位症患者的子宫内膜和/或内异症样本及30例健康育龄妇女子宫内膜样本,发现IL-10处理可诱导内异症间质细胞促纤维化表型,而敲低STAT3基因可减弱该效应;IL-10对健康妇女子宫内膜间质细胞无显著促纤维化作用;作者认为IL-10和IL-6通过持续STAT3激活的促炎/抗炎信号可能促进内异症纤维化,需进一步体内研究验证。

要点

  • IL-10处理可诱导子宫内膜异位症间质细胞促纤维化表型,敲低STAT3基因可减弱此效应。
  • IL-10对健康妇女子宫内膜间质细胞的促纤维化表型无显著影响。
  • IL-10联合TGF-β1和/或IL-6/sIL-6R序贯处理可诱导STAT3持续激活并显著增加肌成纤维细胞增殖及I型胶原蛋白表达。

核心结论

  • IL-10在子宫内膜异位症中并非抗纤维化而是促纤维化,因其体外处理内异症间质细胞可促进肌成纤维细胞增殖和I型胶原蛋白表达。

研究设计与样本

  • 分析54例有深部子宫内膜异位症组织学证据患者的子宫内膜和/或内异症样本,以及30例健康育龄妇女子宫内膜样本,进行体外研究。

主要发现

  • IL-10诱导内异症间质细胞促纤维化表型(细胞增殖、I型胶原合成、α-平滑肌肌动蛋白阳性应力纤维及胶原凝胶收缩)。
  • 敲低STAT3基因可减少IL-10诱导的内异症间质细胞促纤维化表型。
  • IL-10对健康妇女子宫内膜间质细胞的促纤维化表型无显著影响。
  • IL-10联合或不联合TGF-β1和/或IL-6/sIL-6R序贯处理可诱导STAT3持续激活并显著增加内异症间质细胞中肌成纤维细胞增殖及I型胶原蛋白表达。
  • TGF-β1和/或IL-6/sIL-6R处理显著增加TIMP1蛋白表达,而IL-10无显著影响;敲低STAT3基因显著减少TGF-β1和/或IL-6/sIL-6R诱导的TIMP1蛋白表达。

关键数值与推荐

  • 在健康妇女子宫内膜间质细胞中,TGF-β1和/或IL-6/sIL-6R处理前给予IL-10预处理以及IL-10联合或不联合TGF-β1和/或IL-6/sIL-6R的序贯处理均显著减少成纤维细胞(无α-平滑肌肌动蛋白阳性应力纤维的细胞)增殖及I型胶原蛋白表达。

临床怎么用

  • 作者认为,IL-10和IL-6通过持续STAT3激活的抗炎信号可能促进子宫内膜异位症纤维化。
  • 作者建议,针对「炎症」的抑制性治疗策略可能失调「促炎与抗炎介质」的交叉调控,对子宫内膜异位症患者产生不良影响如纤维化。
  • 作者提出,为开发新的且无害的治疗策略,需研究「抗炎介质」与促炎介质在个体子宫内膜异位症患者中的参与情况、方式及种类。

局限性

  • 鉴于子宫内膜异位症病理生理学中涉及大量复杂的促炎和抗炎介质相互作用及信号通路,本研究仅探讨了其中很小一部分。
  • 需进一步体内研究验证本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is interleukin-10 (IL-10) anti-fibrotic in endometriosis? SUMMARY ANSWER: IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis, because IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression. WHAT IS KNOWN ALREADY: We previously showed that persistent activation of signal transducer and activator of transcription 3 (STAT3) via IL-6 trans-signaling promotes fibrosis of endometriosis. Studies showed marked anti-fibrotic effects of IL-10 via the STAT3 signaling pathway, which is generally considered to be anti-inflammatory, in various organs. STUDY DESIGN, SIZE, DURATION: Endometrial and/or endometriotic samples of 54 patients who had histological evidence of deep endometriosis, and endometrial samples from 30 healthy fertile women were analyzed. PARTICIPANTS/MATERIALS, SETTING, METHODS: The effects of IL-10/STAT3 signaling as well as inhibition of STAT3 activation by knockdown of STAT3 gene on the pro-fibrotic phenotype in endometrial and endometriotic stromal cells in vitro were investigated. Then, the effects of various time points of IL-10 treatment in combination with transforming growth factor (TGF)-β1 and/or IL-6/soluble IL-6 receptor (sIL-6R) on the profibrotic phenotype of endometrial and endometriotic stromal cells were investigated. MAIN RESULTS AND THE ROLE OF CHANCE: IL-10 induced pro-fibrotic phenotype (cell proliferation, collagen type I synthesis, α-smooth muscle actin positive stress fibers and collagen gel contraction) of endometriotic stromal cells. Knockdown of STAT3 gene decreased the IL-10 induced pro-fibrotic phenotype of endometriotic stromal cells. In contrast, IL-10 had no significant effects on pro-fibrotic phenotype of endometrial stromal cells of healthy women. Sequential IL-10 treatment with or without TGF-β1 and/or IL-6/sIL-6R induced persistent activation of STAT3 and significantly increased proliferation of myofibroblasts (cells with α-smooth muscle actin positive stress fibers) and protein expression of collagen type I in endometriotic stromal cells. TGF-β1 and/or IL-6/sIL6RIL-6/sIL6R treatment significantly increased tissue inhibitor of metalloproteinase 1 (TIMP1) protein expression, whereas IL-10 had no significant effects. Knockdown of STAT3 gene significantly decreased the TGF-β1 and/or IL-6/sIL6R induced TIMP1 protein expression. In contrast, pre-treatment with IL-10 before TGF-β1 and/or IL-6/sIL-6R treatment and sequential IL-10 treatment with or without TGF-β1 and/or IL-6/sIL-6R significantly decreased proliferation of fibroblasts (cells without α-smooth muscle actin positive stress fibers) and collagen type I protein expression in endometrial stromal cells of healthy women. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Given the large number of complex interactions and signaling pathways of pro- and anti-inflammatory mediators that are involved in the pathophysiology of endometriosis, the present study investigated only a very small portion of the whole. Further in vivo studies are required to validate the present findings. WIDER IMPLICATIONS OF THE FINDINGS: Inflammatory mediators in the pathophysiology of endometriosis have been extensively investigated as potential therapeutic targets. However, the present study showed that anti-inflammatory signals of IL-10 and IL-6 through persistent STAT3 activation may promote endometriosis fibrosis. Therapeutic strategies, such as suppression of 'inflammation', might dysregulate the cross-regulation of 'pro- and anti-inflammatory mediators', leading to detrimental effects in patients with endometriosis, such as fibrosis. To develop new, but not deleterious, therapeutic strategies, studies are required to investigate whether, how and what 'anti-inflammatory mediators' along with pro-inflammatory mediators are involved in individual patients with endometriosis. STUDY FUNDING/COMPETING INTEREST(S): This study was supported in part by KARL STORZ SE & Co. KG (Tuttlingen, Germany). The authors have no conflict of interest to disclose.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Matsuzaki S, Pouly JL, Canis M, et al. IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression. Hum Reprod. 2023. PMID: 36413036. doi:10.1093/humrep/deac248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。